252 related articles for article (PubMed ID: 27847320)
41. Overexpression of S100A4 Predicts Migration, Invasion, and Poor Prognosis of Hypopharyngeal Squamous Cell Carcinoma.
Xu J; Gross N; Zang Y; Cao S; Yang F; Yang Z; Yu W; Lei D; Pan X
Mol Diagn Ther; 2019 Jun; 23(3):407-417. PubMed ID: 30868407
[TBL] [Abstract][Full Text] [Related]
42. Structure-based design of highly selective 2,4,5-trisubstituted pyrimidine CDK9 inhibitors as anti-cancer agents.
Shao H; Foley DW; Huang S; Abbas AY; Lam F; Gershkovich P; Bradshaw TD; Pepper C; Fischer PM; Wang S
Eur J Med Chem; 2021 Mar; 214():113244. PubMed ID: 33581551
[TBL] [Abstract][Full Text] [Related]
43. Platinum compounds sensitize ovarian carcinoma cells to ABT-737 by modulation of the Mcl-1/Noxa axis.
Simonin K; N'Diaye M; Lheureux S; Loussouarn C; Dutoit S; Briand M; Giffard F; Brotin E; Blanc-Fournier C; Poulain L
Apoptosis; 2013 Apr; 18(4):492-508. PubMed ID: 23344663
[TBL] [Abstract][Full Text] [Related]
44. Discovery of 4-(((4-(5-chloro-2-(((1s,4s)-4-((2-methoxyethyl)amino)cyclohexyl)amino)pyridin-4-yl)thiazol-2-yl)amino)methyl)tetrahydro-2H-pyran-4-carbonitrile (JSH-150) as a novel highly selective and potent CDK9 kinase inhibitor.
Wang B; Wu J; Wu Y; Chen C; Zou F; Wang A; Wu H; Hu Z; Jiang Z; Liu Q; Wang W; Zhang Y; Liu F; Zhao M; Hu J; Huang T; Ge J; Wang L; Ren T; Wang Y; Liu J; Liu Q
Eur J Med Chem; 2018 Oct; 158():896-916. PubMed ID: 30253346
[TBL] [Abstract][Full Text] [Related]
45. miR-107 Targets NSG1 to Regulate Hypopharyngeal Squamous Cell Carcinoma Progression through ERK Pathway.
Hu Y; He Z; Han B; Lin Z; Zhou P; Li S; Huang S; Chen X
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892156
[TBL] [Abstract][Full Text] [Related]
46. STI-571 (Gleevec) potentiates the effect of cisplatin in inhibiting the proliferation of head and neck squamous cell carcinoma in vitro.
Wang-Rodriguez J; Lopez JP; Altuna X; Chu TS; Weisman RA; Ongkeko WM
Laryngoscope; 2006 Aug; 116(8):1409-16. PubMed ID: 16885745
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of cell growth and up-regulation of MAD2 in human oesophageal squamous cell carcinoma after treatment with the Src/Abl inhibitor dasatinib.
Wang L; Guo B; Wang R; Jiang Y; Qin S; Liang S; Zhao Y; Guo W; Li K; Fan X
Clin Sci (Lond); 2012 Jan; 122(1):13-24. PubMed ID: 21751967
[TBL] [Abstract][Full Text] [Related]
48. Aberrant expression of PHLPP1 and PHLPP2 correlates with poor prognosis in patients with hypopharyngeal squamous cell carcinoma.
Zhou J; Yu X; Wang J; Li T; Jin T; Lei D; Pan X
PLoS One; 2015; 10(3):e0119405. PubMed ID: 25793736
[TBL] [Abstract][Full Text] [Related]
49. Aberrant expression of Beclin-1 and LC3 correlates with poor prognosis of human hypopharyngeal squamous cell carcinoma.
Wang J; Pan XL; Ding LJ; Liu DY; Da-Peng Lei ; Jin T
PLoS One; 2013; 8(7):e69038. PubMed ID: 23935917
[TBL] [Abstract][Full Text] [Related]
50. FOXO3a reactivation mediates the synergistic cytotoxic effects of rapamycin and cisplatin in oral squamous cell carcinoma cells.
Fang L; Wang H; Zhou L; Yu D
Toxicol Appl Pharmacol; 2011 Feb; 251(1):8-15. PubMed ID: 21092744
[TBL] [Abstract][Full Text] [Related]
51. Design and optimization of selective and potent CDK9 inhibitors with flavonoid scaffold for the treatment of acute myeloid leukemia.
Wu T; Yu B; Gong W; Zhang J; Yu S; Tian Y; Zhao T; Li Z; Wang J; Bian J
Eur J Med Chem; 2023 Nov; 259():115711. PubMed ID: 37572539
[TBL] [Abstract][Full Text] [Related]
52. CDK9 Inhibitor Induces Apoptosis, Autophagy, and Suppression of Tumor Growth in Adult T-Cell Leukemia/Lymphoma.
Kato N; Kozako T; Ohsugi T; Uchida Y; Yoshimitsu M; Ishitsuka K; Aikawa A; Honda SI
Biol Pharm Bull; 2023; 46(9):1269-1276. PubMed ID: 37661406
[TBL] [Abstract][Full Text] [Related]
53. lncRNA HOXA11-AS Promotes Proliferation and Migration via Sponging miR-155 in Hypopharyngeal Squamous Cell Carcinoma.
Xu J; Bo Q; Zhang X; Lei D; Wang J; Pan X
Oncol Res; 2020 May; 28(3):311-319. PubMed ID: 31987067
[TBL] [Abstract][Full Text] [Related]
54. Discovery of 2H-benzo[b][1,4]oxazin-3(4H)-one derivatives as potent and selective CDK9 inhibitors that enable transient target engagement for the treatment of hematologic malignancies.
Wang X; Liu X; Huang J; Liu C; Li H; Wang C; Hong Q; Lei Y; Xia J; Yu Z; Dong R; Xu J; Tu Z; Duan C; Li S; Lu T; Tang W; Chen Y
Eur J Med Chem; 2022 Aug; 238():114461. PubMed ID: 35605362
[TBL] [Abstract][Full Text] [Related]
55. miR-15a induces cell apoptosis by targeting BCL2L2 and BCL2 in HPV-positive hypopharyngeal squamous cell carcinoma.
Lu W; Feng L; Zhang Y; Ma Y; Li P; Wang Y; Du Y; Chen X; Wu S; Zhao G; Lou W
Oncol Rep; 2016 Oct; 36(4):2169-76. PubMed ID: 27573302
[TBL] [Abstract][Full Text] [Related]
56. Expression of the long noncoding RNA RP11-169D4.1-001 in Hypopharyngeal Squamous cell carcinoma tissue and its clinical significance.
Shen Z; Wu L; Hao W; Li Q; Zhou C
J Clin Lab Anal; 2020 Jan; 34(1):e23019. PubMed ID: 31512299
[TBL] [Abstract][Full Text] [Related]
57. PDK1 promotes metastasis by inducing epithelial-mesenchymal transition in hypopharyngeal carcinoma via the Notch1 signaling pathway.
Jing P; Zhou S; Xu P; Cui P; Liu X; Liu X; Liu X; Wang H; Xu W
Exp Cell Res; 2020 Jan; 386(2):111746. PubMed ID: 31778670
[TBL] [Abstract][Full Text] [Related]
58. Significance of the expression of integrin β1, VEGF and MVD in hypopharyngeal squamous cell carcinoma.
Hong YM; Gan WG; Xu ZH
Genet Mol Res; 2014 Aug; 13(3):6455-65. PubMed ID: 25158264
[TBL] [Abstract][Full Text] [Related]
59. CDK9 inhibition improves diabetic nephropathy by reducing inflammation in the kidneys.
Yang X; Luo W; Li L; Hu X; Xu M; Wang Y; Feng J; Qian J; Guan X; Zhao Y; Liang G
Toxicol Appl Pharmacol; 2021 Apr; 416():115465. PubMed ID: 33631230
[TBL] [Abstract][Full Text] [Related]
60. Co-expression of ING4 and P53 enhances hypopharyngeal cancer chemosensitivity to cisplatin in vivo.
Ren X; Liu H; Zhang M; Wang M; Ma S
Mol Med Rep; 2016 Sep; 14(3):2431-8. PubMed ID: 27484725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
